Statistics
Publications
61
Citations
9.7K
H-Index
42
Active since
1999
Klaus P. Hoeflich is an author at Blueprint Medicines (United States) specializing in medicine, cell biology, and tumor biology.
Publications per year
1999–2024
61
61
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou, Kyung Song, Ivana Yen et al. · Nature · 2010 · 1.6K citations · Full text
Signaling Pathway, Receptor Tyrosine Kinase, Mapk Pathway +8
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Klaus P. Hoeflich, Juan Luo, Elizabeth A. Rubie et al. · Nature · 2000 · 1.4K citations
Signal Transduction, Signaling Pathway, Molecular Pathway +11
1–5 of 61